Stimulant Drugs and Stimulant Use Disorder.
Song W, Simona A, Zhang P, Bates DW, Urman RD.
Anesthesiol Clin. 2024 Mar;42(1):103-115. doi: 10.1016/j.anclin.2023.09.003. Epub 2023 Oct 3.
Revisiting stimulant use for emotional dysregulation in attention-deficit/hyperactivity disorder (ADHD).
Brancati GE, Acierno D, Barbuti M, Elefante C, Gemignani S, Raia A, Perugi G.
Expert Rev Neurother. 2023 Jul-Dec;23(11):981-994. doi: 10.1080/14737175.2023.2263645. Epub 2023 Oct 27.
The mesocorticolimbic system in stimulant use disorder.
London ED, Groman SM, Leyton M, de Wit H.
Mol Psychiatry. 2025 Nov;30(11):5486-5499. doi: 10.1038/s41380-025-03148-0. Epub 2025 Sep 10.
Stimulant Use Disorders.
Park TM, Haning WF 3rd.
Child Adolesc Psychiatr Clin N Am. 2016 Jul;25(3):461-71. doi: 10.1016/j.chc.2016.02.004. Epub 2016 Mar 28.
Novel therapeutics in development for the treatment of stimulant-use disorder.
Young EJ, Radnai L, Prikhodko V, Miller CA.
Curr Opin Neurobiol. 2024 Aug;87:102898. doi: 10.1016/j.conb.2024.102898. Epub 2024 Aug 2.
Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.
Greenhill LL, Pliszka S, Dulcan MK, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S; American Academy of Child and Adolescent Psychiatry.
J Am Acad Child Adolesc Psychiatry. 2002 Feb;41(2 Suppl):26S-49S. doi: 10.1097/00004583-200202001-00003.
Severity of stimulant use disorder by psychostimulant type and polystimulant use pattern.
Schepis TS, Veliz PT, McCabe VV, Werner KS, Pasman E, Wilens TE, McCabe SE.
Exp Clin Psychopharmacol. 2025 Jun;33(3):275-284. doi: 10.1037/pha0000761. Epub 2025 Feb 27.
The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.
Ciccarone D.
Curr Opin Psychiatry. 2021 Jul 1;34(4):344-350. doi: 10.1097/YCO.0000000000000717.
The potential for misuse and abuse of medications in ADHD: a review.
Clemow DB, Walker DJ.
Postgrad Med. 2014 Sep;126(5):64-81. doi: 10.3810/pgm.2014.09.2801.
Impact of Central Nervous System Stimulant Medication Use on Growth in Pediatric Populations with Attention-Deficit/Hyperactivity Disorder: A Review.
Troksa K, Kovacich N, Moro M, Chavez B.
Pharmacotherapy. 2019 Jun;39(6):665-676. doi: 10.1002/phar.2192. Epub 2018 Nov 21.
